Live Zoster Vaccine in Patients With Rheumatoid Arthritis Treated With Tofacitinib With or Without Methotrexate, or Adalimumab With Methotrexate: A Post Hoc Analysis of Data From a Phase IIIb/IV Randomized Study

OBJECTIVE: To explore herpes zoster (HZ) rates and live zoster vaccine (LZV) safety in a subset of patients with rheumatoid arthritis who received LZV before tofacitinib ± methotrexate (MTX), or adalimumab (ADA) plus MTX in the ORAL Strategy. METHODS: ORAL Strategy was a 1‐year, phase IIIb/IV, rando...

Descripción completa

Detalles Bibliográficos
Autores principales: Calabrese, Leonard H., Abud‐Mendoza, Carlos, Lindsey, Stephen M., Lee, Sang‐Heon, Tatulych, Svitlana, Takiya, Liza, Iikuni, Noriko, Soma, Koshika, Luo, Zhen, Fleischmann, Roy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Rheumatoid Arthritis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7064887/
https://www.ncbi.nlm.nih.gov/pubmed/31207152
http://dx.doi.org/10.1002/acr.24010

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7064887/
https://www.ncbi.nlm.nih.gov/pubmed/31207152
http://dx.doi.org/10.1002/acr.24010

Ejemplares similares